69 related articles for article (PubMed ID: 9102151)
21. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
22. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
23. [Is the topography of Alzheimer's disease lesions a clue to their pathogenesis?].
Duyckaerts C; Bennecib M; Grignon Y; Piette F; Hauw JJ
Bull Acad Natl Med; 1996 Oct; 180(7):1703-14. PubMed ID: 9102152
[TBL] [Abstract][Full Text] [Related]
24. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
Beckman M
Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
[No Abstract] [Full Text] [Related]
25. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
Crouch PJ; White AR; Bush AI
FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
[TBL] [Abstract][Full Text] [Related]
26. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
Shepherd CE; Gregory GC; Vickers JC; Halliday GM
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
[TBL] [Abstract][Full Text] [Related]
27. [Morphologic and molecular neuropathology of Alzheimer's disease].
Duyckaerts C; Panchal M; Delatour B; Potier MC
Ann Pharm Fr; 2009 Mar; 67(2):127-35. PubMed ID: 19298896
[TBL] [Abstract][Full Text] [Related]
28. The involvement of the ubiquitin system in Alzheimer's disease (review).
Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
30. Current advances in research in Alzheimer's disease.
Perry E
Recenti Prog Med; 1989 Dec; 80(12):692-700. PubMed ID: 2697903
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease.
Hardy JA; Davies DC
Br J Hosp Med; 1988 May; 39(5):372-3, 376-7. PubMed ID: 3289659
[TBL] [Abstract][Full Text] [Related]
32. The complexities of the pathology-pathogenesis relationship in Alzheimer disease.
Castellani RJ; Perry G
Biochem Pharmacol; 2014 Apr; 88(4):671-6. PubMed ID: 24447936
[TBL] [Abstract][Full Text] [Related]
33. Two types of senile plaque.
Rosenblum WI
J Neuropathol Exp Neurol; 1996 Jan; 55(1):131-2. PubMed ID: 8558167
[No Abstract] [Full Text] [Related]
34. Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects.
Hochstrasser T; Marksteiner J; Defrancesco M; Deisenhammer EA; Kemmler G; Humpel C
Dement Geriatr Cogn Dis Extra; 2011 Jan; 1(1):297-309. PubMed ID: 22545041
[TBL] [Abstract][Full Text] [Related]
35. The role of adenosine in Alzheimer's disease.
Rahman A
Curr Neuropharmacol; 2009 Sep; 7(3):207-16. PubMed ID: 20190962
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid nerve growth factor levels in patients with Alzheimer's disease.
Mashayekhi F; Salehin Z
Ann Saudi Med; 2006; 26(4):278-82. PubMed ID: 16883086
[TBL] [Abstract][Full Text] [Related]
37. [Alzheimer's disease lesions: from morphology to cell biology].
Hauw JJ; Seilhean D; Piette F; Uchihara T; Duyckaerts C
Bull Acad Natl Med; 1996 Oct; 180(7):1687-700; discussion 1700-1. PubMed ID: 9102151
[TBL] [Abstract][Full Text] [Related]
38. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
39. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
